Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiumin Wu
Institutions:
Second Affiliated Hospital of Chongqing Medical University,
Chongqing Medical University
Observed institutions:
Second Affiliated Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0009-0006-2786-2593
Observed ORCID:
0009-0006-2786-2593
OpenAlex ID:
A5151796307
Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma
2024
·
Chongyang Zhou
, Qiumin Wu
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Supplementary Figure S4 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S5 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S3 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Data from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S7 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S9 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S6 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S2 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S10 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S8 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S11 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary tables S1-7 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S1 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
Supplementary Figure S12 from EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
2026
·
Huiying Gu
, Fan Li
, et al.
·
Cancer Research
Lipid droplet-associated gene signatures classify metabolic subtypes and identify PLIN3 as a key driver in hepatocellular carcinoma
2026
·
Huiying Gu
, Qiumin Wu
, et al.
·
Genes & Diseases
Show more works
View as search
Works count:
17
Citation count:
12
H-index:
1
I10-index:
1
Year
Topic
Type